Table 6 MTT cytotoxicity analysis of Lp-CM-ChT80 and Lp-CM-ChT80-DTX liposomes.

From: In silico ADMET profiling of Docetaxel and development of camel milk derived liposomes nanocarriers for sustained release of Docetaxel in triple negative breast cancer

S.No

Concentration

Docetaxel

Lp-CM-ChT80

Lp-CM-ChT80-DTX

% cytotoxicity

1

5 µg/ml

25.5

16.4

52.3

2

16 µg/ml

51.5

16.3

60.7

3

22 µg/ml

55.1

15.6

65.2